CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-12 | SCHIMMEL PAUL Director | Conversion · Series A Redeemable Convertible Preferred Stock | −525,000 | 0 | ||
| 2015-05-12 | SCHIMMEL PAUL Director | Conversion · Series B Redeemable Convertible Preferred Stock | −1,200,000 | 0 | ||
| 2015-05-12 | SCHIMMEL PAUL Director | Conversion · Series B-2 Redeemable Convertible Preferred Stock | −1,440,058 | 0 | ||
| 2015-05-12 | SCHIMMEL PAUL Director | Conversion · Series C Redeemable Convertible Preferred Stock | −558,508 | 0 | ||
| 2015-05-12 | SCHIMMEL PAUL Director | Conversion · Series D Redeemable Convertible Preferred Stock | −15,031 | 0 | ||
| 2015-05-12 | SCHIMMEL PAUL Director | Conversion · Series E Redeemable Convertible Preferred Stock | −446,827 | 0 | ||
| 2015-05-12 | Sofinnova Venture Partners IX, L.P. 10% owner | Conversion | +1,546,126 | 1,546,126 | ||
| 2015-05-12 | Sofinnova Venture Partners IX, L.P. 10% owner | Purchase | +320,000 | $14.00 | $4.5M | 1,866,126 |
| 2015-05-12 | Sofinnova Venture Partners IX, L.P. 10% owner | Conversion · Series E Redeemable Convertible Preferred Stock | −14,968,722 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +1,674,825 | 1,674,825 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +32,642 | 32,642 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +11,472 | 11,472 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +16,748 | 16,748 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +89,069 | 1,763,894 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +1,736 | 34,378 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +610 | 12,082 | ||
| 2015-05-12 | Nashat Amir Director | Conversion | +890 | 17,638 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series B Redeemable Convertible Preferred Stock | −3,473,763 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series B Redeemable Convertible Preferred Stock | −67,704 | 0 | ||
| 2015-05-12 | Nashat Amir Director | Conversion · Series B Redeemable Convertible Preferred Stock | −23,796 | 0 |
Page 22 of 25 · 483 trades